Baker Botts represented Novacap and its Portfolio Company Cadent, while McDermott Will & Emery represented AdTheorent Holding Company in the transaction. Cadent, one of the largest...
You must be a Standard 1 Year member to access this content.
Baker Botts advised DISH DBS Corp. DISH Technologies, L.L.C., and Sling TV L.L.C on the deal. DISH DBS Corp. DISH Technologies, L.L.C., and Sling TV L.L.C...
You must be a Standard 1 Year member to access this content.
Goodwin Procter and Appleby advised Alvarium Investments on the deal. Seward & Kissel represented Tiedemann Advisors and TIG Advisors. Homburger advised Tiedemann Group and its Switzerland-based...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer advised Cirkul on the deal. Consumer-tech beverage client Cirkul, a producer of flavored cartridges and proprietary water bottles, announced its $70 million Series C...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised Senti Biosciences, while Davis Polk advised Dynamics Special Purpose Corp. on the deal. Senti Biosciences (“Senti Bio”) announced its definitive business combination agreement with...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis and Gernandt & Danielsson advised Cint Group AB on the deal, while Goodwin Procter represented Lucid Holdings, LLC. Cint Group AB (publ), a...
You must be a Standard 1 Year member to access this content.
Goodwin Procter advised G Squared Ascend I on the deal. Latham & Watkins represented Transfix. G Squared Ascend I (NYSE: GSQD), a special purpose acquisition company...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Chiasma, Inc. on the deal. Chiasma, Inc. (Nasdaq: CHMA) announced its definitive agreement to be acquired by Amryt Pharma plc (Nasdaq: AMYT, AIM:...
You must be a Standard 1 Year member to access this content.
Goodwin Procter LLP advised Rubius Therapeutics on the deal. Rubius Therapeutics (NASDAQ: RUBY) announced the upsized underwritten public offering of 6,896,552 shares of its common stock at...
You must be a Standard 1 Year member to access this content.
